CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• The role of CD4+FOXP3+ regulatory T cells (Tregs) in human immunodeficiency virus (HIV) infection is debated, complicated by quantification uncertainties and conflicting findings.
• HIV infection affects Tregs, but they appear preferentially preserved compared to conventional CD4 T cells, leading to apparent discrepancies in earlier studies.
• The dual immune defects in HIV infection—chronic inflammation and impaired specific responses—further complicate understanding Treg impact.

Purpose of the Study:

• To review current data on Treg fate and function in HIV infection, considering both global Treg populations and distinct subsets.
• To explore how identifying naive and effector Treg subsets may reconcile contrasting findings on Treg roles in HIV.
• To discuss the potential impact of HIV on mechanisms regulating adaptive Treg differentiation.

Main Methods:

• Review of existing literature on Treg quantification, function, and subsets in the context of HIV infection.
• Analysis of studies investigating Treg preservation and susceptibility to HIV infection.
• Discussion of phenotypic and functional distinctions between Treg subsets.

Main Results:

• Tregs are targets of HIV but are preferentially preserved relative to conventional CD4 T cells.
• Tregs exhibit a dual role in HIV infection, potentially suppressing beneficial immune responses or detrimental chronic inflammation.
• Distinct Treg subsets (naive and effector) may explain these contrasting effects.

Conclusions:

• The identification of distinct Treg subsets offers a framework to reconcile conflicting data on Treg function in HIV infection.
• Understanding Treg subset dynamics is crucial for deciphering their complex influence on HIV pathogenesis and immune control.
• Further research into Treg differentiation mechanisms in HIV is warranted to clarify their precise role.